A detailed history of Dimensional Fund Advisors LP transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 20,372 shares of JANX stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,372
Previous 24,019 15.18%
Holding current value
$1.02 Million
Previous $1.01 Million 8.05%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$35.29 - $50.26 $128,702 - $183,298
-3,647 Reduced 15.18%
20,372 $925,000
Q2 2024

Aug 09, 2024

BUY
$35.12 - $64.78 $295,780 - $545,577
8,422 Added 54.0%
24,019 $1.01 Million
Q1 2024

May 10, 2024

BUY
$7.93 - $49.75 $123,684 - $775,950
15,597 New
15,597 $587,000

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.1B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.